<DOC>
	<DOCNO>NCT02809040</DOCNO>
	<brief_summary>Hypertensive heart disease ( HHD ) heart condition cause chronic exposure high blood pressure . In patient HHD , abnormalities way heart muscle relaxes heart chamber passively fill blood ( diastolic dysfunction ) occur may detect echocardiography ( echo ) , standard clinical method examine heart structure function use reflect sound wave . Investigators propose develop digital auscultation system electronic stethoscope base wireless sensor node technique . Investigators hypothesize heart sound measurement detect electronic stethoscope use detect heart diastolic dysfunction HHD .</brief_summary>
	<brief_title>E_Stethoscope : Portable Digital Auscultation Study Hypertensive/Hypertensive Heart Disease Patients</brief_title>
	<detailed_description>Study proposal aim look treatment Hypertension ( HT ) complication exact high healthcare cost . In 2004 , Singapore adult prevalence hypertension 20.1 % . WHO estimate HT cause 4.5 % global disease burden , 62 % cerebrovascular disease 49 % ischemic heart disease attributable suboptimal blood pressure ( BP ) control . Recently , scrutiny focus appropriate BP level initiate HT treatment benefit strict BP target otherwise uncomplicated HT question , HT drug treatment without risk . This underscore need stratify HT subject accord target organ damage , affect HT patient may select intensive BP lowering . Hypertensive heart disease ( HHD ) heart condition cause chronic exposure high BP . As population age , HT HHD prevalence increase . Genetic hemodynamic factor interact cause HHD patient hypertension . In patient HHD , abnormalities myocardial relaxation passive filling may detect sometimes echocardiography ( echo ) . These diastolic dysfunction due various mechanisms central pathophysiology increase myocardial stiffness . Early symptom myocardial stiffness cause left ventricular hypertrophy ( LVH ) good early indicator cardiovascular target organ damage patient HT HHD . HHD subject constitute group intensive BP treatment drug strict target show yield favourable benefit risk ratio . As , identification HHD subject becomes paramount . An electrocardiogram ( ECG ) monitor record heart 's electrical activity . ECG insensitive detect diastolic dysfunction sensitivity 12 % 50 % . An echo take picture heart use ultrasound . Echo use diagnose diastolic function , however , one single echo parameter make diagnosis . Multiple echo parameter propose include mitral inflow velocity pattern , pulmonary vein flow pattern tissue Doppler measurement , imprecise . Existing ultrasound scan cost range US $ 300- $ 600 reimbursable Medicaid ( payer ) . A coronary angiography examines flow blood heart insert catheter heart . It invasive costly . Therefore , appeal need cheap non-invasive solution would able detect diastolic function . That large impact patient management payer . A cheap , non-invasive sensitive solution permit detection via auscultation abnormal heart sound , indicate stiff heart muscle associate HHD among HT subject critically need . Cardiac auscultation ( listen heart sound ) possible option heart sound associated myocardial function dysfunction .In normal heart , two heart sound ( S1 S2 ) audible , correspond closure mitral aortic heart valves respectively . A third heart sound S3 , occur S2 present heart failure . A fourth heart sound S4 , occur S1 , due forceful contraction atrium overcome stiff hypertrophic leave ventricle . Human ears well equip detect abnormities consistently conventional stethoscope . Therefore , investigator propose develop low power , non-invasive , portable device base Wireless Sensor Node ( WSN ) technology achieve goal portable auscultation . Our propose device allow u monitor/record heart sound in-situ perform preliminary assessment diastolic function physiologically meaningful , reproducible validate . Multiple device also place use concurrently different site torso enhance chance detect abnormal heart sound .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<criteria>1 . Participants clinically suspect know HT/HDD schedule echocardiography examination and/or cardiac catheterization . 2 . Participants history high BP stable medication least 2 week . 3 . Presence follow : Elevated BP measurement Left ventricular hypertrophy ( LVH ) either prior ECG prior echo . Exclusion Criteria patient 1 . Participants heart muscle disease . 2 . Participants significance valve disease . Exclusion Criteria volunteer : 1 . Strictly exclude hypertensive Normal healthy volunteer . 2 . Not antihypertensive agent .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>